+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bristol-Myers Squibb - logo

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

HPV Associated Disorders Market Report 2025 - Product Thumbnail Image

HPV Associated Disorders Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Human Papillomavirus (HPV) Associated Disorders Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Thumbnail Image

Human Papillomavirus (HPV) Associated Disorders Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • March 2025
  • 185 Pages
  • Global
From
Cervical Cancer Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Thumbnail Image

Cervical Cancer Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • March 2025
  • 185 Pages
  • Global
From
Mycosis Fungoides Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Mycosis Fungoides Therapeutics - Global Strategic Business Report

  • Report
  • July 2025
  • 182 Pages
  • Global
From
Non-Hodgkin Lymphoma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Non-Hodgkin Lymphoma Therapeutics - Global Strategic Business Report

  • Report
  • July 2025
  • 192 Pages
  • Global
From
Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics - Global Strategic Business Report

  • Report
  • July 2025
  • 273 Pages
  • Global
From
Treatment Resistant Depression Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Treatment Resistant Depression Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • October 2022
  • 292 Pages
  • Global
From
Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 1814 Pages
  • Global
From
Retinal Drugs and Biologics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Retinal Drugs and Biologics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • May 2023
  • 93 Pages
  • Global
From
Plaque Psoriasis - Global Drug Forecast and Market Analysis to 2030 - Product Thumbnail Image

Plaque Psoriasis - Global Drug Forecast and Market Analysis to 2030

  • Report
  • November 2021
  • 108 Pages
  • Global
From
Generics Market: Focus on Value-Added Medicines / Supergenerics, 2019-2030 - Product Thumbnail Image

Generics Market: Focus on Value-Added Medicines / Supergenerics, 2019-2030

  • Report
  • October 2019
  • 231 Pages
  • Global
From
Lenalidomide Market by Type and by Application, by End-User, and By Region - Product Thumbnail Image

Lenalidomide Market by Type and by Application, by End-User, and By Region

  • Report
  • March 2024
  • 200 Pages
  • Global
From
Breast Cancer Drugs Market Size, Share & Trends Analysis Report By Therapy (Targeted, Hormonal), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By Cancer Type (Hormone Receptor, HER2+), And Segment Forecasts, 2023-2030 - Product Thumbnail Image

Breast Cancer Drugs Market Size, Share & Trends Analysis Report By Therapy (Targeted, Hormonal), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By Cancer Type (Hormone Receptor, HER2+), And Segment Forecasts, 2023-2030

  • Report
  • June 2023
  • 180 Pages
  • Global
From
Schizoaffective Drug Market by Therapeutic Class, Treatment, by End-Users, and By Region - Product Thumbnail Image

Schizoaffective Drug Market by Therapeutic Class, Treatment, by End-Users, and By Region

  • Report
  • March 2024
  • 200 Pages
  • Global
From
Cancer Vaccines Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Cancer Vaccines Market - Forecasts from 2024 to 2029

  • Report
  • August 2024
  • 135 Pages
  • Global
From
Antiviral Drugs Market Report and Forecast 2023-2031 - Product Thumbnail Image

Antiviral Drugs Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 232 Pages
  • Global
From
Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 628 Pages
  • Global
From
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 820 Pages
  • Global
From
Advanced Cervical Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Cervical Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 160 Pages
  • Global
From
Loading Indicator